MYCN and neuroblastoma: We acquired ssGSEA scores of the four NB subtypes in our dataset, and found immunogenic and metabolic markers were both in low levels among the three clusters, while Hi-MYCN-NB was obvious expressed in C3, which owns the most high-risk samples.